Last reviewed · How we verify
NCT06584903
Safe Indoor Temperature Limit for Fans
NA trial testing Temperature Ramp Protocol in Heat Exposure in 10 participants. Completed in 30 April 2024.
30 April 2024
Quick facts
| Lead sponsor | Lakehead University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 10 |
| Start date | 20 January 2024 |
| Primary completion | 30 April 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Temperature Ramp Protocol
Conditions studied
- Heat Exposure — all drugs for Heat Exposure →
- Healthy — all drugs for Healthy →
- Young Adults — all drugs for Young Adults →
- Fans — all drugs for Fans →
Sponsor
Lakehead University
Who can join
Adults 19 to 39, any sex, with Heat Exposure or Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Extreme heat events are a significant global threat to health and wellbeing, and result in more morbidity and mortality than all other natural disasters combined. Thus, a key priority is identifying effective and accessible heat resilience solutions to protect individuals from the potentially fatal consequences of heat stress. Within a range of ambient conditions, a fan has been recognized a low-cost heat resilience solution. However, when ambient temperatures exceed skin temperatures (e.g., above 35°C), a fan will incur greater dry heat gain which may be counterbalanced with evaporation of sweat from the skin surface. However, at a critical indoor temperature, the rate of heat gain will exceed the rate of evaporation resulting in net heat gain. The critical indoor temperature has yet to be determined. The purpose of this present study is to identify the indoor temperature at which a fan results in greater cardiovascular and thermal strain relative to still air in young adults using a simulated heat wave scenario of a warming room.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06584903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heat Exposure
Currently open trials in the same condition.
- NCT07032493 — Identifying the Limits of Survivability in Heat-exposed Older Females · NA · recruiting
- NCT06982339 — Beat the Heat Boston · NA · recruiting
- NCT06551168 — Heat Acclimation in Females · NA · recruiting
Other Lakehead University trials
Trials by the same sponsor.
- NCT06469762 — The Short-Term Effects of Dry Cupping the Lumbar Paraspinal Muscles in Individuals With Non-specific Low Back Pain · NA · completed
- NCT06154369 — JoyPop Mobile Mental Health App With Post-Secondary Students · NA · completed
- NCT05991154 — JoyPop Mobile Mental Health App With Indigenous Transitional-Aged Youth · NA · recruiting
- NCT06402929 — Honest, Open, Proud - College for Post-Secondary Students With Mental Health Challenges · NA · completed
- NCT05586477 — Diphenhydramine and Sweating · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06584903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lakehead University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06584903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing